Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-04-03FDA Approved: AMLODIPINE AND VALSARTAN — Original Application (Alembic Pharmaceuticals Limited)
The FDA approved Alembic Pharmaceuticals' original application for a fixed-dose combination of amlodipine and valsartan, a generic hypertens…
-
FDA approval · 2015-04-02FDA Approved: MOEXIPRIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Moexipril hydrochloride from Teva Pharmaceuticals USA, Inc., updating an existing approval f…
-
FDA approval · 2015-03-31FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved a supplemental application to add a 25 mg strength of Losartan Potassium Tablets, expanding the product's dosage options. The a…
-
FDA approval · 2015-03-30FDA Approved: AMLODIPINE AND VALSARTAN — Original Application (Lupin Pharmaceuticals,Inc.)
FDA approves Lupin's amlodipine and valsartan fixed-dose combination tablet under an original ANDA for the treatment of hypertension.
-
FDA approval · 2015-03-30FDA Approved: AMLODIPINE AND VALSARTAN — Original Application (Mylan Pharmaceuticals Inc.)
The FDA approved Mylan's original ANDA for a generic fixed-dose combination of amlodipine and valsartan for the treatment of hypertension.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-03-30FDA Approved: AMLODIPINE AND VALSARTAN — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' original application for a generic amlodipine/valsartan combination.
-
FDA approval · 2015-03-27FDA Approved: ALISKIREN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for ALISKIREN (Aliskiren hemifumarate) from Prasco Laboratories.
-
FDA approval · 2015-03-25FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for the irbesartan and hydrochlorothiazide combination from Teva Pharmaceuticals USA, enabling its m…
-
FDA approval · 2015-03-23FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for the fixed-dose combination of amlodipine and atorvastatin, manufactured by Prasco Laboratories. …
-
FDA approval · 2015-03-23FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Norvasc (amlodipine besylate) submitted by Viatris Specialty LLC to update the labeling.
-
FDA approval · 2015-03-20FDA Approved: ATENOLOL — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for Atenolol from Ipca Laboratories Limited under the ANDA, granting approval for changes related to…
-
FDA approval · 2015-03-20FDA Approved: TERAZOSIN — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved a supplemental application for terazosin hydrochloride from Jubilant Cadista Pharmaceuticals Inc., related to the generic teraz…
-
FDA approval · 2015-03-18FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for METOPROLOL TARTRATE by Mylan Pharmaceuticals Inc., confirming approval of the generic product.
-
FDA approval · 2015-03-02FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for the generic combination irbesartan and hydrochlorothiazide manufactured by Hikma Pharmaceuticals…
-
FDA approval · 2015-03-02FDA Approved: MOEXIPRIL HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's Moexipril hydrochloride under a supplemental ANDA, expanding the availability of a generic Moexipril product.
-
FDA approval · 2015-02-27FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved a generic fixed-dose combination of candesartan cilexetil and hydrochlorothiazide from Macleods Pharmaceuticals Limited.
-
FDA approval · 2015-02-24FDA Approved: DOXAZOSIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for doxazosin mesylate from Aurobindo Pharma Limited.
-
FDA approval · 2015-02-23FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Method Pharmaceuticals, LLC)
The FDA approves a supplemental application for labetalol hydrochloride from Method Pharmaceuticals, LLC.
-
FDA approval · 2015-02-23FDA Approved: IRBESARTAN — Original Application (AvKARE)
FDA approved AvKARE's original generic application for irbesartan (IRBESARTAN). Irbesartan is used to treat hypertension.
-
FDA approval · 2015-02-18FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for the Irbesartan and Hydrochlorothiazide fixed-dose combination from Macleods Pharmaceuticals Limi…
-
FDA approval · 2015-02-17FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for a generic fixed-dose combination tablet of amlodipine besylate and atorvastatin calcium (AML…
-
FDA approval · 2015-02-13FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for Losartan Potassium from Solco Healthcare US, LLC.
-
FDA approval · 2015-02-13FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for the generic irbesartan/hydrochlorothiazide product from Aurobindo Pharma Limited.
-
FDA approval · 2015-02-13FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva Pharmaceuticals USA, Inc. to market a generic fixed-dose combination of losartan potassium …
-
FDA approval · 2015-02-09FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental NDA for the combination antihypertensive candesartan cilexetil and hydrochlorothiazide from ANI Pharmaceutic…